Manufacturing Enterprise "Academpharm"

https://academpharm.by/  

Medicinal product "Telmisartan-NAN" tablets, 40 mg and 80 mg

COUNTRY OF ORIGIN

Belarus

IDENTIFIER

BO3984

PUBLISHED

2021-06-19

LAST UPDATE

2021-06-20

DEADLINE

Linked profile in other language
Responsible
Natalia Safronova
production@academpharm.by
Summary
The State-owned Enterprise ACADEMPHARM offers consumers the drug "Telmisartan-NAN" tablets, 40 mg and 80 mg under a manufacturing agreement and is looking for partners to conclude a distribution services agreement.
Description
The state registration of the generic drug "Telmisartan-NAN" 40 mg and 80 mg tablets in a blister strip No. 14x2, No. 15x2 was carried out at the Ministry of Health of the Republic of Belarus. The laboratory technology for the preparation of a drug based on telmisartan was scaled up under the conditions of production of the State Enterprise "Academpharm".
Advantages and Innovations
The price of the domestic generic drug Telmisartan-NAN is 10..40% lower than the price of imported analogues.
Stage of development
Already on the market
Funding source
State budged
Internal
IPR status
Secret know-how
Sector group
Healthcare

Client information

Type
R&D institution
Year established
2009
NACE keywords
M.72.11 - Research and experimental development on biotechnology
M.74.90 - Other professional, scientific and technical activities n.e.c.
Q.86.90 - Other human health activities
Turnover (in EUR)
10-20M
Already engaged in transnational cooperation
Yes
Languages spoken
English
Russian

Information about partnership

Type of partnership considered
Distribution services agreement
Manufacturing agreement
Type and role of partner sought
Consumers interested in purchasing the drug "Telmisartan-NAN" tablets, 40 mg and 80 mg under a manufacturing agreement.

Distributors interested in purchasing the drug "Telmisartan-NAN" tablets, 40 mg and 80 mg under a distribution services agreement.
Type and size of partner sought
> 500 MNE
> 500
251-500
SME 51-250
SME 11-50
SME <= 10

Attachments

Количество уникальных просмотров в одной сессии: 54
Статистика ведется с 20.06.2021 20:57:08